Tevogen Bio Holdings Inc.
TVGN
$5.40
$0.020.37%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 19.95M | 20.16M | 21.89M | 23.43M | 17.11M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 30.89M | 31.25M | 34.40M | 53.56M | 46.21M |
| Operating Income | -30.89M | -31.25M | -34.40M | -53.56M | -46.21M |
| Income Before Tax | -31.04M | -31.20M | -35.36M | -13.73M | -7.92M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -31.04 | -31.20 | -35.36 | -13.73 | -7.92 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -31.04M | -31.20M | -35.36M | -13.73M | -7.92M |
| EBIT | -30.89M | -31.25M | -34.40M | -53.56M | -46.21M |
| EBITDA | -30.72M | -31.04M | -34.24M | -53.40M | -46.04M |
| EPS Basic | -10.69 | -10.93 | -11.37 | -4.29 | -7.22 |
| Normalized Basic EPS | -6.62 | -6.79 | -7.81 | -12.56 | -12.74 |
| EPS Diluted | -10.94 | -11.18 | -11.65 | -21.16 | -24.08 |
| Normalized Diluted EPS | -6.62 | -6.79 | -7.81 | -12.33 | -12.50 |
| Average Basic Shares Outstanding | 12.97M | 12.45M | 11.85M | 11.37M | 9.73M |
| Average Diluted Shares Outstanding | 12.97M | 12.45M | 11.85M | 11.47M | 9.83M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |